Exane Derivatives’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,645
| Closed | -$53.7K | – | 926 |
|
|
2022
Q1 | $53.7K | Buy |
+5,645
| New | +$53.7K | 0.02% | 562 |
|
|
2021
Q4 | – | Sell |
-5,368
| Closed | -$179K | – | 964 |
|
|
2021
Q3 | $179K | Sell |
5,368
-3,563
| -40% | -$119K | 0.04% | 409 |
|
|
2021
Q2 | $346K | Hold |
8,931
| – | – | 0.08% | 246 |
|
|
2021
Q1 | $430K | Sell |
8,931
-2,651
| -23% | -$128K | 0.12% | 158 |
|
|
2020
Q4 | $602K | Buy |
11,582
+1,288
| +13% | +$67K | 0.18% | 117 |
|
|
2020
Q3 | $275K | Sell |
10,294
-4,286
| -29% | -$115K | 0.08% | 171 |
|
|
2020
Q2 | $284K | Sell |
14,580
-3,858
| -21% | -$75.1K | 0.08% | 181 |
|
|
2020
Q1 | $181K | Buy |
18,438
+18,003
| +4,139% | +$177K | 0.05% | 195 |
|
|
2019
Q4 | $6.13K | Hold |
435
| – | – | ﹤0.01% | 408 |
|
|
2019
Q3 | $2.44K | Hold |
435
| – | – | ﹤0.01% | 447 |
|
|
2019
Q2 | $3.76K | Hold |
435
| – | – | ﹤0.01% | 464 |
|
|
2019
Q1 | $3.5K | Hold |
435
| – | – | ﹤0.01% | 397 |
|
|
2018
Q4 | $1.78K | Hold |
435
| – | – | ﹤0.01% | 492 |
|
|
2018
Q3 | $2.64K | Sell |
435
-9,399
| -96% | -$57.1K | ﹤0.01% | 443 |
|
|
2018
Q2 | $132K | Hold |
9,834
| – | – | 0.02% | 279 |
|
|
2018
Q1 | $139K | Buy |
+9,834
| New | +$139K | 0.03% | 249 |
|